Interim recommendations for use of the Bharat Biotech BBV152 COVAXIN® vaccine against COVID-19 - update 15 March 2022

These WHO interim recommendations for use of the BBV152 COVAXIN vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes.

Auteurs